The Impact of COVID-19 is included in Radiopharmaceutical Theranostics Market Report. Buy it today to get an advantage.
Request the impact of COVID-19 on your product or industry
Radiopharmaceutical Theranostics Trends and Forecast
The future of the global radiopharmaceutical theranostics market looks promising with opportunities in the hospital, diagnostic imaging center, and academic & research institute markets. The global radiopharmaceutical theranostics market is expected to reach an estimated $3.9 billion by 2030 with a CAGR of 11.2% from 2024 to 2030. The major drivers for this market are increasing incidence of cancer and rising application in treatment of cardiovascular disorders.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Radiopharmaceutical Theranostics by Segment
The study includes a forecast for the global radiopharmaceutical theranostics by product type, source, indication, end use, and region.
Radiopharmaceutical Theranostics Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:
• Alpha Emitters
• Beta Emitters
• PET Tracers
Radiopharmaceutical Theranostics Market by Source [Shipment Analysis by Value from 2018 to 2030]:
• Nuclear Reactors
• Cyclotrons
Radiopharmaceutical Theranostics Market by Indication [Shipment Analysis by Value from 2018 to 2030]:
• Oncology
• Cardiology
• Neurology
• Others
Radiopharmaceutical Theranostics Market by End Use [Shipment Analysis by Value from 2018 to 2030]:
• Hospitals
• Diagnostic Imaging Centers
• Academic & Research Institutes
• Others
Radiopharmaceutical Theranostics Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Radiopharmaceutical Theranostics Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies radiopharmaceutical theranostics companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the radiopharmaceutical theranostics companies profiled in this report include-
• Bayer
• GE Healthcare Technologies
• Curium
• Lantheus Medical Imaging
• Telix Pharmaceuticals
• Cardinal Health
• Advanced Accelerator Applications
• Jubilant Radiopharma
• Theragnostics
• Nuview Life Sciences
Radiopharmaceutical Theranostics Market Insights
Lucintel forecasts that PET tracers is expected to witness highest growth over the forecast period.
Within this market, hospitals will remain the largest segment due to availability of technologically advanced systems and rising number of hospitals.
North America is expected to witness highest growth over the forecast period due to the growing prevalence of chronic diseases and easy availability of radiopharmaceuticals and pet scanners in the region.
Features of the Global Radiopharmaceutical Theranostics Market
Market Size Estimates: Radiopharmaceutical theranostics market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Radiopharmaceutical theranostics market size by various segments, such as by product type, source, indication, end use, and region in terms of value ($B).
Regional Analysis: Radiopharmaceutical theranostics market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different product types, sources, indications, end uses, and regions for the radiopharmaceutical theranostics market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the radiopharmaceutical theranostics market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q.1 What is the radiopharmaceutical theranostics market size?
Answer: The global radiopharmaceutical theranostics market is expected to reach an estimated $3.9 billion by 2030.
Q.2 What is the growth forecast for radiopharmaceutical theranostics market?
Answer: The global radiopharmaceutical theranostics market is expected to grow with a CAGR of 11.2% from 2024 to 2030.
Q.3 What are the major drivers influencing the growth of the radiopharmaceutical theranostics market?
Answer: The major drivers for this market are increasing incidence of cancer and rising application in treatment of cardiovascular disorders.
Q4. What are the major segments for radiopharmaceutical theranostics market?
Answer: The future of the global radiopharmaceutical theranostics market looks promising with opportunities in the hospital, diagnostic imaging center, and academic & research institute markets.
Q5. Who are the key radiopharmaceutical theranostics market companies?
Answer: Some of the key radiopharmaceutical theranostics companies are as follows:
• Bayer
• GE Healthcare Technologies
• Curium
• Lantheus Medical Imaging
• Telix Pharmaceuticals
• Cardinal Health
• Advanced Accelerator Applications
• Jubilant Radiopharma
• Theragnostics
• Nuview Life Sciences
Q6. Which radiopharmaceutical theranostics market segment will be the largest in future?
Answer: Lucintel forecasts that PET tracers is expected to witness highest growth over the forecast period.
Q7. In radiopharmaceutical theranostics market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness highest growth over the forecast period due to the growing prevalence of chronic diseases and easy availability of radiopharmaceuticals and pet scanners in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the radiopharmaceutical theranostics market by product type (alpha emitters, beta emitters, and PET tracers), source (nuclear reactors and cyclotrons), indication (oncology, cardiology, neurology, and others), end use (hospitals, diagnostic imaging centers, academic & research institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Radiopharmaceutical Theranostics Market, Radiopharmaceutical Theranostics Market Size, Radiopharmaceutical Theranostics Market Growth, Radiopharmaceutical Theranostics Market Analysis, Radiopharmaceutical Theranostics Market Report, Radiopharmaceutical Theranostics Market Share, Radiopharmaceutical Theranostics Market Trends, Radiopharmaceutical Theranostics Market Forecast, Radiopharmaceutical Theranostics Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.
Table of Contents
1. Executive Summary
2. Global Radiopharmaceutical Theranostics Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Radiopharmaceutical Theranostics Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Radiopharmaceutical Theranostics Market by Product Type
3.3.1: Alpha Emitters
3.3.2: Beta Emitters
3.3.3: PET Tracers
3.4: Global Radiopharmaceutical Theranostics Market by Source
3.4.1: Nuclear Reactors
3.4.2: Cyclotrons
3.5: Global Radiopharmaceutical Theranostics Market by Indication
3.5.1: Oncology
3.5.2: Cardiology
3.5.3: Neurology
3.5.4: Others
3.6: Global Radiopharmaceutical Theranostics Market by End Use
3.6.1: Hospitals
3.6.2: Diagnostic Imaging Centers
3.6.3: Academic & Research Institutes
3.6.4: Others
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Radiopharmaceutical Theranostics Market by Region
4.2: North American Radiopharmaceutical Theranostics Market
4.2.2: North American Radiopharmaceutical Theranostics Market by End Use: Hospitals, Diagnostic Imaging Centers, Academic & Research Institutes, and Others
4.3: European Radiopharmaceutical Theranostics Market
4.3.1: European Radiopharmaceutical Theranostics Market by Product Type: Alpha Emitters, Beta Emitters, and PET Tracers
4.3.2: European Radiopharmaceutical Theranostics Market by End Use: Hospitals, Diagnostic Imaging Centers, Academic & Research Institutes, and Others
4.4: APAC Radiopharmaceutical Theranostics Market
4.4.1: APAC Radiopharmaceutical Theranostics Market by Product Type: Alpha Emitters, Beta Emitters, and PET Tracers
4.4.2: APAC Radiopharmaceutical Theranostics Market by End Use: Hospitals, Diagnostic Imaging Centers, Academic & Research Institutes, and Others
4.5: ROW Radiopharmaceutical Theranostics Market
4.5.1: ROW Radiopharmaceutical Theranostics Market by Product Type: Alpha Emitters, Beta Emitters, and PET Tracers
4.5.2: ROW Radiopharmaceutical Theranostics Market by End Use: Hospitals, Diagnostic Imaging Centers, Academic & Research Institutes, and Others
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Radiopharmaceutical Theranostics Market by Product Type
6.1.2: Growth Opportunities for the Global Radiopharmaceutical Theranostics Market by Source
6.1.3: Growth Opportunities for the Global Radiopharmaceutical Theranostics Market by Indication
6.1.4: Growth Opportunities for the Global Radiopharmaceutical Theranostics Market by End Use
6.1.5: Growth Opportunities for the Global Radiopharmaceutical Theranostics Market by Region
6.2: Emerging Trends in the Global Radiopharmaceutical Theranostics Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Radiopharmaceutical Theranostics Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Radiopharmaceutical Theranostics Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: Bayer
7.2: GE HealthCare Technologies
7.3: Curium
7.4: Lantheus Medical Imaging
7.5: Telix Pharmaceuticals
7.6: Cardinal Health
7.7: Advanced Accelerator Applications
7.8: Jubilant Radiopharma
7.9: Theragnostics
7.10: NuView Life Sciences
.
Buy full report or by chapter as follows
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Please sign in below to get report brochure - Radiopharmaceutical Theranostics Market Report.